Pragmatic Trial Tests Telehealth Strategies to Boost Lung Cancer Screening Shared Decision-Making — SMART Design Targets Health Equity

References

1. 1.Abramson Cancer Center at Penn Medicine. (2024). Integrating Telehealth to Advance Lung Cancer Screening. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT06638554
2. 2.Almirall, D., Nahum-Shani, I., Sherwood, N. E., & Murphy, S. A. (2014). Introduction to SMART designs for the development of adaptive interventions. Clinical Trials, 11(4), 437-445. https://doi.org/10.1177/1740774514536566
3. 3.Carter-Harris, L., Gould, M. K., Munshi, S., Ribeiro Dos Santos, L., Winkel, G., & Crothers, K. (2017). The role of social determinants in lung cancer screening. Clinical Chest Medicine, 38(3), 545-558. https://doi.org/10.1016/j.ccm.2017.04.010
4. 4.Ford, I., & Norrie, J. (2016). Pragmatic trials. New England Journal of Medicine, 375(5), 454-463. https://doi.org/10.1056/NEJMra1510059
5. 5.Jemal, A., & Fedewa, S. A. (2017). Lung cancer screening with low-dose computed tomography in the United States—2010 to 2015. JAMA Oncology, 3(9), 1278-1281. https://doi.org/10.1001/jamaoncol.2016.6416
6. 6.Lei, H., Nahum-Shani, I., Lynch, K., Oslin, D., & Murphy, S. A. (2012). A SMART design for building individualized treatment sequences. Annual Review of Clinical Psychology, 8, 21-48. https://doi.org/10.1146/annurev-clinpsy-032511-143152
7. 7.Marshall, H. M., Bowman, R. V., Yang, I. A., Fong, K. M., & Berg, C. D. (2013). Screening for lung cancer with low-dose computed tomography: a review of current status. Journal of Thoracic Disease, 5(4), 524-539. https://doi.org/10.3978/j.issn.2072-1439.2013.06.15
8. 8.Mazzone, P. J., Silvestri, G. A., Patel, S., Kanne, J. P., Kinsinger, L. S., Wiener, R. S., Soo Hoo, G., & Detterbeck, F. C. (2021). Screening for lung cancer: CHEST guideline and expert panel report. Chest, 160(5), e427-e494. https://doi.org/10.1016/j.chest.2021.06.063
9. 9.Richards, T. B., Doria-Rose, V. P., Soman, A., Klabunde, C. N., Caraballo, R. S., Gray, S. C., Houston, K. A., & White, M. C. (2020). Lung cancer screening inconsistent with US Preventive Services Task Force recommendations. American Journal of Preventive Medicine, 58(2), 241-249. https://doi.org/10.1016/j.amepre.2019.07.030
10. 10.Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(3), 233-254. https://doi.org/10.3322/caac.21763
11. 11.US Preventive Services Task Force. (2021). Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA, 325(10), 962-970. https://doi.org/10.1001/jama.2021.1117